Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation
Jooyoung Kim, Young‐Ok Son, Soon‐Won Park, et al.
Experimental & Molecular Medicine (2006) Vol. 38, Iss. 5, pp. 474-484
Open Access | Times Cited: 180

Showing 26-50 of 180 citing articles:

Radiation Therapy and the In Situ Vaccination Approach
Encouse B. Golden, Ariel E. Marciscano, Silvia C. Formenti
International Journal of Radiation Oncology*Biology*Physics (2020) Vol. 108, Iss. 4, pp. 891-898
Open Access | Times Cited: 70
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Yuan‐Bo Pan, Wei Tang, Wenpei Fan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 23, pp. 9759-9830
Open Access | Times Cited: 68
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
IPSC-derived CAR-NK cells for cancer immunotherapy
Xiaotong Lin, Yao Sun, Xin Dong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115123-115123
Open Access | Times Cited: 26
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 12
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Immunogenicity of anthracyclines: moving towards more personalized medicine
Lionel Apétoh, Grégoire Mignot, Theocharis Panaretakis, et al.
Trends in Molecular Medicine (2008) Vol. 14, Iss. 4, pp. 141-151
Closed Access | Times Cited: 115
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
Alice Hervieu, Cédric Rébé, Frédérique Végran, et al.
Journal of Investigative Dermatology (2012) Vol. 133, Iss. 2, pp. 499-508
Open Access | Times Cited: 82
Immune recognition of irradiated cancer cells
Erik Wennerberg, Claire Vanpouille‐Box, Sophia Bornstein, et al.
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 220-230
Open Access | Times Cited: 80
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
Mira M. Shenouda, Amy Gillgrass, Tina Nham, et al.
Breast Cancer Research (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 76
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
Zishuo I. Hu, Alice Y. Ho, Heather L. McArthur
International Journal of Radiation Oncology*Biology*Physics (2017) Vol. 99, Iss. 1, pp. 153-164
Closed Access | Times Cited: 74
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities
Ariel E. Marciscano, Adriana Haimovitz–Friedman, Percy Lee, et al.
International Journal of Radiation Oncology*Biology*Physics (2019) Vol. 110, Iss. 1, pp. 35-52
Closed Access | Times Cited: 72
In-situ tumor vaccination: Bringing the fight to the tumor
Robert H. Pierce, Jean S. Campbell, Sara I. Pai, et al.
Human Vaccines & Immunotherapeutics (2015) Vol. 11, Iss. 8, pp. 1901-1909
Open Access | Times Cited: 69
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
Mandy van Gulijk, Floris Dammeijer, Joachim G.J.V. Aerts, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 67
Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
Qiuji Wu, Awatef Allouch, Isabelle Martins, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 63
Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer
Xin Zhang, Dong Wang, Zhidong Li, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
Song-Xin Zhu, Yuming Wang, Jun Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Amber B. Jones, Abbey Rocco, Lawrence S. Lamb, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2339-2339
Open Access | Times Cited: 32
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
Ge Tan, Katelyn M. Spillane, John Maher
Biology (2023) Vol. 12, Iss. 8, pp. 1079-1079
Open Access | Times Cited: 18
Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
Barış Emre Dayanç, Sarah H. Beachy, Julie R. Ostberg, et al.
International Journal of Hyperthermia (2008) Vol. 24, Iss. 1, pp. 41-56
Open Access | Times Cited: 91
Quercetin Enhances Susceptibility to NK Cell-mediated Lysis of Tumor Cells Through Induction of NKG2D Ligands and Suppression of HSP70
Jae‐Ho Bae, Jooyoung Kim, Mi‐Ju Kim, et al.
Journal of Immunotherapy (2010) Vol. 33, Iss. 4, pp. 391-401
Closed Access | Times Cited: 67
Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
Sung‐Min Lee, Beomseok Son, Gaeul Park, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2795-2795
Open Access | Times Cited: 56
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Claire Lhuillier, Claire Vanpouille‐Box, Lorenzo Galluzzi, et al.
Seminars in Cancer Biology (2017) Vol. 52, pp. 125-134
Open Access | Times Cited: 54
Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody
Hong-Rae Lee, Cheol‐Hun Son, Eun-Kyoung Koh, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 53

Scroll to top